NBIX earnings date and history (2026)
Neurocrine Biosciences Inc. (NBIX) has no scheduled report date on the calendar yet. Its last report, on Mon Nov 2, came in at $2.78 against a $1.95 consensus; the stock moved +13.4% on the news. Not investment advice.
See every company reporting on the earnings calendar or the filed financial statements.
Past reports#
Data provided bySource: Twelve DataNewest first. The surprise is the reported EPS against the consensus going in, in percent; the move is the stock’s close-to-close change over the first session that could trade on the report, shown once that session has settled and only where the report’s timing is established — the earnings calendar, the time the company filed its earnings release with the SEC and the day’s trading volume, by majority.
| Date | Est | Actual | Move |
|---|---|---|---|
| Nov 2, 2026 | $1.95 | $2.78 | +13.4% |
| Jul 30, 2026 | $1.88 | $2.36 | -10.1% |
| May 5, 2026 | $1.28 | $1.41 | +8.9% |
| Feb 11, 2026 | $1.78 | $1.43 | -10.4% |
| Oct 28, 2025 | $1.58 | $2.04 | -6.4% |
| Jul 30, 2025 | $0.98 | $1.06 | -6.2% |
| May 5, 2025 | $0.43 | $0.08 | +8.4% |
| Feb 6, 2025 | $1.56 | $1.00 | -18.5% |
| Oct 30, 2024 | $1.47 | $1.24 | +7.0% |
| Aug 1, 2024 | $1.15 | $0.63 | +8.2% |
| May 1, 2024 | $1.04 | $0.42 | +4.0% |
| Feb 7, 2024 | $1.13 | $1.44 | -4.7% |
| Oct 31, 2023 | $0.91 | $0.82 | +3.6% |
| Aug 1, 2023 | $0.77 | $0.95 | +1.5% |
| May 3, 2023 | $0.26 | -$0.79 | -4.7% |
| Feb 6, 2023 | $1.15 | $0.88 | -4.6% |
| Nov 1, 2022 | $0.84 | $0.69 | +3.7% |
| Aug 4, 2022 | $0.56 | -$0.18 | +8.5% |
| May 4, 2022 | $0.33 | $0.14 | -0.3% |
| Feb 11, 2022 | $0.61 | -$0.08 | +7.4% |
| Nov 1, 2021 | $0.51 | $0.23 | -10.0% |
| Aug 3, 2021 | $0.52 | $0.43 | -4.6% |
About this data#
Report dates, sessions, consensus EPS estimates, reported EPS and surprises are third-party figures, subject to change, and may not be accurate. A quarter whose session is known is shown with it; for one whose session is not, the move is left blank rather than guessed, because a pre-open and an after-close report trade on different sessions. The move is ChartRow's own: the first settled close that could trade on the report over the close before it, price return. Not investment advice.
FAQ#
- Did NBIX beat earnings last quarter?
- Yes: on Mon Nov 2 NBIX reported $2.78 against a $1.95 consensus, a +42.6% surprise.
- How did NBIX stock react to its last earnings?
- NBIX moved +13.4% on its last earnings report. It reported on Mon Nov 2, 2026, after the close, so the first trading session that could react was Tue Nov 3. NBIX closed at $145.35 on Mon Nov 2 and at $164.85 on Tue Nov 3, and $164.85 ÷ $145.35 − 1 = +13.4%. Both are ChartRow's own settled closing prices.
